封面
市場調查報告書
商品編碼
1454252

全球兒童用灌流市場:按產品類型、按應用、按最終用戶、按地區

Global Pediatric Perfusion Market, By Product Type, By Application, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 180 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2023年,全球兒童用灌流市場規模為5.747億美元,2024年至2031年年複合成長率(CAGR)為5.4%,預計到2031年將達到8.753億美元。

報告範圍 報告詳情
基準年 2023年 2023/2024年市場規模 5.747 億美元
實際資料 2019-2023 預測期 2024-2031
預測期間2023/2024 至2030/2031年年複合成長率: 5.40% 2030/2031價值預測 8.753 億美元
圖 1.2024年依地區分類的兒童用灌流全球市場佔有率(%)
全球兒科灌流市場-IMG1

兒童用灌流是指在心臟直視手術期間接受心肺體外迴圈(CPB)的兒童透過循環系統輸送血液。 CPB 包括透過心肺機轉移患者的血液循環,以維持肺部的循環和氣體交換,同時在手術修復的某些部分心臟停止跳動。兒童用灌流需要專門的設備、技術和技能,以適應成人和兒童患者之間的解剖和生理差異。在過去的幾十年裡,灌流技術的進步、電路設計的改進以及兒童手術技術的創新顯著提高了手術的成功率。然而,先天性心臟疾病仍然是全世界嬰幼兒死亡的主要原因之一。

市場動態:

世界衛生組織(WHO)估計,近 1%的新生兒患有先天性心臟疾病(CHD)。診斷技術的進步使得早期發現冠心病成為可能,再加上兒童心臟手術的進步,提高了存活率和治療結果。因此,越來越多的兒童受益於兒童心血管手術,進而受益於兒童用灌流服務。

兒童用灌流在心血管手術期間使用心肺機來支持兒童的心肺功能。隨著越來越多的新生兒和嬰兒被診斷出患有先心病並接受翻修或姑息手術,對專用灌流設備的需求不斷增加。外科手術的進步使得複雜的心血管手術可以更早進行,延長了兒童先心病患者的壽命和生活品質。

然而,兒童用灌流市場也面臨挑戰。兒童心血管手術的高昂費用可能會對醫療保健系統和家庭造成沉重的經濟負擔,特別是在沒有全面醫療保險覆蓋的地區。此外,兒童用灌流需要專業知識,並且缺乏訓練有素的兒童用灌流師。另一個挑戰是對非體外循環手術的日益關注,這可能會限制沖洗設備的市場。由於這些手術是在不停止心臟的情況下進行的,因此不需要心肺機,並且可能會減少對灌流服務的需求。

儘管有這些挑戰,兒童用灌流市場仍存在重大機會,特別是在小型灌流設備的創新和開拓方面。這些設備更適合新生兒和嬰兒的生理需求,提供更精確的控制和更少的併發症。這是兒童心臟護理領域的重大進步,為該市場的參與者提供了一個有吸引力的機會。新興市場也存在成長潛力,這些市場的醫療基礎設施日益擴大,兒童心臟護理的普及程度改善。這些地區對醫療保健服務的需求迅速成長,這可能會推動市場擴張。

總之,隨著醫學的不斷進步,如果能夠策略性地解決成本、培訓和技術方面的挑戰,全球兒童用灌流市場就有望實現成長。製造商和醫療保健提供者可以透過投資專為兒童護理設計的專業、經濟高效且技術先進的灌流系統來利用這些機會。

本研究的主要特點

  • 本報告對全球兒童用灌流市場進行了詳細分析,並提供了預測期內(2024-2031年,以2023年為基準年)的市場規模和年複合成長率(CAGR%)。
  • 強調了各個細分市場的潛在收益成長機會,並說明了該市場有吸引力的投資提案矩陣。
  • 提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
  • 根據公司亮點、產品系列、主要亮點,實績和策略等參數,介紹了全球兒童用灌流市場的主要企業。
  • 本報告的見解使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
  • 全球兒童用灌流市場報告針對該行業的各個相關人員,如投資者、供應商、產品製造商、經銷商、新進入者和財務分析師。
  • 透過用於分析全球兒童用灌流市場的各種策略矩陣,將促進相關人員的決策。

目錄

第1章 研究目的與前提

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章 市場動態、法規及趨勢分析

  • 市場動態
  • 影響分析
  • 主要亮點
  • 監管場景
  • 產品發布/核准
  • PEST分析
  • 波特的分析
  • 併購場景

第4章 全球兒童用灌流市場-冠狀病毒(COVID-19)大流行的影響

  • 新型冠狀病毒感染疾病(COVID-19)的流行病學
  • 供需面分析
  • 經濟影響

第5章 全球兒童用灌流市場,依產品類型,2019-2031

  • 兒童用插管
  • 離心血泵
  • 兒童動脈管
  • 膜式充氧器
  • 體外迴路
  • 其他

第6章 全球兒童用灌流市場,依應用分類,2019-2031

  • 心血管外科
  • 呼吸應用
  • 體外膜氧合
  • 心肺體外迴圈
  • 器官灌流與保存
  • 器官移植
  • 其他

第7章 全球兒童用灌流市場,依最終使用者分類,2019-2031年

  • 醫院
  • 專科診所
  • 門診手術中心
  • 其他

第8章 2019-2031年全球兒童用灌流市場(依地區)

  • 北美洲
  • 美國
  • 加拿大
  • 歐洲
  • 2019-2031年市場規模及依產品類型預測、與前一年同期比較成長率
  • 2019-2031年市場規模與應用預測、與前一年同期比較成長率
  • 市場規模和最終用戶預測,與前一年同期比較成長率,2019-2031
  • 2019-2031年市場規模及各國預測、與前一年同期比較成長率
  • 英國
  • 德國
  • 義大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 歐洲其他地區
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • ASEAN
  • 其他亞太地區
  • 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 海灣合作理事會國家
  • 以色列
  • 其他中東地區
  • 非洲
  • 南非
  • 北非
  • 中部非洲

第9章 競爭格局

  • Medtronic
  • GE Healthcare
  • LivaNova, PLC.
  • Getinge
  • Braile Biomedica
  • XENIOS AG
  • BL Lifesciences
  • Terumo Corporation
  • 3M
  • Koninklijke Philips NV
  • EUROSETS
  • Merck KGaA
  • Stryker
  • Cardinal Health
  • Nonin
  • Sorin Group USA, Inc.

第10章

  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI6673

The global pediatric perfusion market size was valued at US$ 574.7 Mn in 2023 and is expected to reach US$ 875.3 Mn by 2031 growing at a compound annual growth rate (CAGR) of 5.4% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2023/2024: US$ 574.7 Mn
Historical Data for: 2019 to 2023 Forecast Period: 2024 - 2031
Forecast Period 2023/2024 to 2030/2031 CAGR: 5.40% 2030/2031 Value Projection: US$ 875.3 Mn
Figure 1. Global Pediatric Perfusion Market Share (%), by Region, 2024
Global Pediatric Perfusion Market - IMG1

Pediatric perfusion is the delivery of blood through the circulatory system in children undergoing cardiopulmonary bypass (CPB) during open heart surgery. CPB involves diverting the patient's blood circulation through a heart-lung machine to maintain circulation and lung gas exchange while the heart is stopped during specific parts of the surgical repair. Pediatric perfusion requires specialized equipment, techniques, and skills to handle the anatomical and physiological differences between adult and pediatric patients. Over the past few decades, procedural success rates have significantly improved due to advancements in perfusion technologies, circuit design modifications, and innovations in surgical techniques tailored for children. However, congenital heart defects continue to be one of the major causes of infant mortality worldwide.

Market Dynamics:

The global pediatric perfusion market is experiencing growth primarily due to the increasing incidence of congenital heart diseases (CHD), a condition affecting nearly 1% of live births according to World Helath Organization (WHO) estimates. Improved diagnostic techniques have led to the early identification of CHD, which, coupled with advancements in pediatric cardiac surgical procedures, has improved survival rates and outcomes. Consequently, this has elevated the number of children who can benefit from pediatric cardiac surgeries and, by extension, pediatric perfusion services.

Pediatric perfusion involves the use of a heart-lung machine to support the child's cardiopulmonary functions during cardiac surgery. As more newborns and infants are diagnosed with CHD and undergo corrective or palliative surgeries, the demand for specialized perfusion equipment has grown. The surgical advancements have allowed for complex cardiac interventions to be performed at earlier stages of life, extending the longevity and quality of life of pediatric CHD patients.

However, the pediatric perfusion market does face challenges. The high cost of pediatric cardiac surgeries can be a significant financial burden for healthcare systems and families, particularly in regions without comprehensive health insurance coverage. Moreover, pediatric perfusion requires specific expertise, and there is a recognized gap in the availability of trained pediatric perfusionists. Another challenge is the increasing focus on off-pump surgical procedures, which can limit the market for perfusion equipment. These surgeries, performed without stopping the heart, may not require a heart-lung machine, thereby decreasing the demand for perfusion services.

Despite these challenges, there are substantial opportunities in the pediatric perfusion market, particularly in the innovation and development of miniaturized perfusion equipment. These devices are better suited for the physiological needs of neonates and infants, offering more precise control and reduced complications. This represents a significant advancement in pediatric cardiac care, offering an attractive opportunity for players in the market. There is also potential for growth in emerging markets, where healthcare infrastructure is expanding, and access to pediatric cardiac care is improving. The burgeoning demand for healthcare services in these regions can stimulate market expansion.

In summary, as medical advancements continue, the global pediatric perfusion market is well-positioned for growth, provided that challenges around costs, training, and technology are strategically addressed. Manufacturers and healthcare providers can capitalize on these opportunities by investing in specialized, cost-effective, and technologically advanced perfusion systems designed for pediatric care.

Key Features of the Study:

  • This report provides an in-depth analysis of the global pediatric perfusion market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2024-2031, considering 2023 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global pediatric perfusion market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Medtronic, GE Healthcare, LivaNova, PLC., Getinge, Braile Biomedica, XENIOS AG, BL Lifesciences, Terumo Corporation, 3M, Koninklijke Philips N.V., EUROSETS, Merck KGaA, Stryker, Cardinal Health, Nonin, and Sorin Group USA, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global pediatric perfusion market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pediatric perfusion market

Detailed Segmentation:

  • By Product Type:
    • Pediatric Cannulas
    • Centrifugal Blood Pumps
    • Pediatric Arterial Lines
    • Membrane Oxygenators
    • Extracorporeal Circuits
    • Others
  • By Application
    • Cardiovascular Surgery
    • Respiratory Applications
    • Extracorporeal Membrane Oxygenation
    • Cardiopulmonary Bypass
    • Organ Perfusion and Preservation
    • Organ Transplantation
    • Others
  • By End User
    • Hospitals
    • Specialty Clinics
    • Ambulatory Surgical Centers
    • Others
  • By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Top Companies in the Global Pediatric Perfusion Market:
    • Medtronic
    • GE Healthcare
    • LivaNova, PLC.
    • Getinge
    • Braile Biomedica
    • XENIOS AG
    • BL Lifesciences
    • Terumo Corporation
    • 3M
    • Koninklijke Philips N.V.
    • EUROSETS
    • Merck KGaA
    • Stryker
    • Cardinal Health
    • Nonin
    • Sorin Group USA, Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Pediatric Perfusion Market, By Product Type
    • Pediatric Perfusion Market, By Application
    • Pediatric Perfusion Market, By End User
    • Pediatric Perfusion Market, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • The increasing incidence of cardiovascular diseases (CVDs) in the pediatric population
    • Increasing government initiatives and funding
    • The emergence of new technologies in pediatric perfusion
    • Technological advancements
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Pediatric Perfusion Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Pediatric Perfusion Market, By Product Type, 2019-2031, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Pediatric Cannulas
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Centrifugal Blood Pumps
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Pediatric Arterial Lines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Membrane Oxygenators
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Extracorporeal Circuits
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)

6. Global Pediatric Perfusion Market, By Application, 2019-2031, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020-2031
    • Segment Trends
  • Cardiovascular Surgery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Respiratory Applications
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Extracorporeal Membrane Oxygenation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Cardiopulmonary Bypass
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Organ Perfusion and Preservation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Organ Transplantation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)

7. Global Pediatric Perfusion Market, By End User, 2019-2031, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020-2031
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Specialty Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)

8. Global Pediatric Perfusion Market, By Region, 2019-2031, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Country, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, For Country, 2020 - 2031
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
  • U.S.
  • Canada
  • Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2031,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019-2031,(US$ Mn)
  • South Africa
  • North Africa
  • Central Africa

9. Competitive Landscape

  • Medtronic
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • GE Healthcare
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • LivaNova, PLC.
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Getinge
  • Braile Biomedica
  • XENIOS AG
  • BL Lifesciences
  • Terumo Corporation
  • 3M
  • Koninklijke Philips N.V.
  • EUROSETS
  • Merck KGaA
  • Stryker
  • Cardinal Health
  • Nonin
  • Sorin Group USA, Inc.
  • Analyst Views

10. Section

  • Research Methodology
  • About us